Troglitazone is no longer available in the United States.
Troglitazone was a prescription medication used to reduce the amount of sugar your body makes and help your body better respond to insulin. This medication was discontinued in 2000 because of the unnecessarily harmful effects it has on the liver. The FDA found that two similar drugs, rosiglitazone and pioglitazone, have the same benefits without this risk to the liver. When it was on the market, troglitazone was part of the drug class of antihyperglycemic agents and was available by brand names Rezulin and Prelay. This medication was used as treatment by people with type II diabetes.
Continue Learning about Pharmacology
Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.